Cargando…

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study

OBJECTIVE: To review the first two years of the primary human papillomavirus (HPV) cervical screening programme in an HPV vaccinated population. DESIGN: Observational study. SETTING: Australia. PARTICIPANTS: 3 745 318 women with a primary HPV test between 1 December 2017 and 31 December 2019; most w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Megan A, Sherrah, Maddison, Sultana, Farhana, Castle, Philip E, Arbyn, Marc, Gertig, Dorota, Caruana, Michael, Wrede, C David, Saville, Marion, Canfell, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965648/ https://www.ncbi.nlm.nih.gov/pubmed/35354610 http://dx.doi.org/10.1136/bmj-2021-068582

Ejemplares similares

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
por: Canfell, Karen, et al.
Publicado: (2017)

Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia
por: Canfell, Karen, et al.
Publicado: (2018)

Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia
por: Sultana, Farhana, et al.
Publicado: (2014)

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia
por: Hall, Michaela T., et al.
Publicado: (2018)

Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
por: Smith, Megan A., et al.
Publicado: (2017)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
por: Simms, Kate T., et al.
Publicado: (2017)

Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening
por: Velentzis, Louiza S., et al.
Publicado: (2023)

Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use
por: Smith, Megan A., et al.
Publicado: (2016)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
por: Arbyn, Marc, et al.
Publicado: (2018)

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
por: Gertig, Dorota M, et al.
Publicado: (2013)

Women’s experience with home-based self-sampling for human papillomavirus testing
por: Sultana, Farhana, et al.
Publicado: (2015)

Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data
por: Smith, Megan A., et al.
Publicado: (2016)

Self‐collection for HPV screening: a game changer in the elimination of cervical cancer
por: Canfell, Karen, et al.
Publicado: (2021)

Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia
por: Brotherton, Julia M.L., et al.
Publicado: (2015)

Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?
por: Arbyn, Marc, et al.
Publicado: (2022)

Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women
por: Baloch, Zulqarnain, et al.
Publicado: (2017)

The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study
por: Bavor, Claire, et al.
Publicado: (2023)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient?
por: Smith, Megan A., et al.
Publicado: (2021)

Expenditure and resource utilisation for cervical screening in Australia
por: Lew, Jie-Bin, et al.
Publicado: (2012)

Implementation of Australia’s primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study
por: Brotherton, Julia M.L., et al.
Publicado: (2023)

Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake
por: Smith, Megan A., et al.
Publicado: (2014)

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction ()
por: Li, Anyie J., et al.
Publicado: (2022)

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand
por: Lew, Jie-Bin, et al.
Publicado: (2016)

Progress in eliminating HPV-associated disease
por: Stern, Peter L., et al.
Publicado: (2019)

HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer
por: Arbyn, Marc, et al.
Publicado: (2022)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology
por: Liu, Ying, et al.
Publicado: (2015)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Knowledge of human papillomavirus (HPV) testing in the USA, the UK and Australia: an international survey
por: Dodd, Rachael H, et al.
Publicado: (2014)

Stakeholder Perspectives of Australia’s National HPV Vaccination Program
por: Swift, Caitlin, et al.
Publicado: (2022)

Dysregulation of host cellular genes targeted by human papillomavirus (HPV) integration contributes to HPV‐related cervical carcinogenesis
por: Zhang, Ruiyang, et al.
Publicado: (2016)

Kosovo women’s knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer
por: Raçi, Pranvera Zejnullahu, et al.
Publicado: (2021)

Human Papillomavirus Genotype Distribution in Czech Women and Men with Diseases Etiologically Linked to HPV
por: Tachezy, Ruth, et al.
Publicado: (2011)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis
por: Mena, Marisa, et al.
Publicado: (2019)

Implementation of Australia’s renewed cervical screening program: Preparedness of general practitioners and nurses
por: Sultana, Farhana, et al.
Publicado: (2020)

Population-based utility scores for HPV infection and cervical squamous cell carcinoma among Australian Indigenous women
por: Ju, Xiangqun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f0jqkn0qhm3nafturhlftcdds1